| 摘要 |
A vasotocin derivative of formula (I) where Hmp is a 2-hydroxy-3-mercaptopropionic acid residue, X is formula (II), Q1 and Q2 are the same or different and are H or from 1 to 3 peptide residues of the same or different natural or unnatural L- or D-amino acids, and n is 1, 2 or 3. A pharmaceutical composition is also described which is intended for use as a vasoconstrictive agent comprising at least one vasotocin derivative as defined above. |
